Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Dean Diagnostic Technology Group Co., Ltd. focuses on third-party diagnostic services as its core business and is committed to providing integrated medical diagnostic solutions. The company was founded in 1996 and went public in July 2011 (stock code: 300244). With the mission of "enabling Chinese people to share health equally", the company actively lays out the industrial ecosystem, covering medical diagnostic services, diagnostic technology research and development, diagnostic product production and marketing, CRO, judicial appraisal, health management, cold chain logistics and other fields.
Headquarter Hangzhou
Establish Date 9/5/2001
Listed Code 300244.SZ
Listed Date 7/19/2011
Chairman Chen Haibin.
CEO Huang Baixing.
Website www.dazd.cn

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial